A-Viton

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of A-Viton

Understanding A-Viton

A-Viton is a pharmacological preparation of Vitamin A, an essential fat-soluble nutrient required for several critical biological processes. It is primarily used to address nutritional deficiencies and support specific physiological functions that depend on adequate Vitamin A levels.

Composition and Mechanism

The active component in A-Viton is Vitamin A, often in the form of retinol or retinyl esters. Once absorbed by the body, it plays a fundamental role in maintaining health at a cellular level. It is particularly involved in:

  • Visual Function: Vitamin A is a precursor to rhodopsin, a pigment in the retina that allows the eyes to detect light, especially in low-light conditions.
  • Immune System Support: It contributes to the maintenance of the body's natural defenses, including the health of skin and mucosal linings that act as barriers against infection.
  • Cellular Growth: It is involved in the process of cell differentiation, ensuring that cells develop and specialize correctly for various organs and tissues.

Clinical Applications

A-Viton is utilized in clinical settings to treat or prevent Vitamin A deficiency. This condition may arise due to inadequate dietary intake, malabsorption disorders, or increased physiological demands. By restoring Vitamin A levels, the medication helps stabilize functions related to vision, epithelial integrity, and overall systemic health.

Physical Characteristics

As a fat-soluble substance, Vitamin A in A-Viton is typically formulated to ensure stable delivery and optimal absorption. Depending on the specific presentation, it is designed to integrate with the body's lipid transport system, allowing the nutrient to be stored in the liver and released as needed by various tissues.

What side effects are possible with A-Viton?

Possible Side Effects and Safety Information: A-Viton

A-Viton (Vitamin A, typically as Retinol or Retinyl Palmitate) is a fat-soluble vitamin. Due to its ability to be stored in the body, excessive or prolonged high-dose intake can lead to toxicity, known as hypervitaminosis A. It is important to adhere strictly to recommended doses, as toxicity can occur from both acute (single very large dose) and chronic (long-term, high dose) over-ingestion.


Potential Adverse Effects

Symptoms of chronic toxicity (Hypervitaminosis A) are generally non-specific and may include:

  • Dermatological: Dry, rough, or peeling skin; cracked lips; hair loss (alopecia).
  • Systemic: Severe headache, fatigue, lethargy, irritability, loss of appetite (anorexia), bone or joint pain.
  • Hepatic: Liver damage (hepatotoxicity) may occur with very high doses over time.

Symptoms of acute toxicity usually appear rapidly after a single massive dose and can include nausea, vomiting, dizziness, headache, and blurred vision.


Contraindications and Interactions

A-Viton is contraindicated (should not be taken) in individuals with high levels of vitamin A (pre-existing hypervitaminosis A) or those with severe liver disease. Infants and young children are particularly susceptible to toxicity at lower doses.

Pregnancy Warning: Excessive intake of preformed Vitamin A during pregnancy, especially in the first trimester, is associated with a risk of birth defects (teratogenicity). Pregnant women, or those who may become pregnant, must consult a healthcare professional regarding safe intake levels.

Drug Interactions: Patients should use caution when combining A-Viton with other medications. Specific interactions include:

  • Retinoids: Use with other oral retinoid medications (e.g., those used for severe acne) can significantly increase the risk of hypervitaminosis A.
  • Tetracyclines: The combination may increase the risk of a rare condition called pseudotumor cerebri (increased pressure around the brain).
  • Warfarin: Very high doses may increase the risk of bruising and bleeding.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of A-Viton (Retinol/Vitamin A) is officially documented by regulatory authorities as Hypervitaminosis A, which can manifest in both acute and chronic forms of toxicity. The profile is based strictly on descriptions found in official government labeling.

Documented Overdose Manifestations

Toxicity Type Officially Listed Clinical Signs
Acute Toxicity Severe headache, vomiting, dizziness, drowsiness, and skin desquamation (peeling).
Chronic Toxicity Fatigue, anorexia, generalized alopecia (hair loss), dry skin, bone/joint pain, and liver function abnormalities.

Required Emergency Actions and Severe Outcomes

The most severe outcome officially documented is the development of Increased Intracranial Pressure (ICP), known as Pseudotumor Cerebri or Benign Intracranial Hypertension (BIH). This condition poses a documented risk of vision impairment.

Immediate medical attention must be sought for any suspected overdose. Urgent medical evaluation is required if symptoms indicative of increased ICP are present, such as persistent severe headache or visual disturbances.

Official regulatory information states that no specific antidote is known for Hypervitaminosis A; therefore, management is primarily symptomatic and supportive, requiring the immediate discontinuation of the A-Viton preparation.

Population-specific considerations noted in labeling include the high susceptibility of infants and small children to acute toxicity, with bulging fontanelles being a specific sign of increased ICP in this group. Excessive intake in pregnant individuals is officially associated with the risk of teratogenicity.

Therapeutic Uses of A-Viton

What A-Viton Treats: Main Uses and Benefits

A-Viton (Retinol/Vitamin A) is commonly used to help with the symptomatic health consequences associated with a deficiency of this nutrient. Its therapeutic benefits are relevant for easing symptoms related to systemic imbalance and assists with functional stability of epithelial tissues. Vitamin A is considered relevant to prevent and treat vision issues related to its lack and to support the immune system.

A-Viton is relevant for easing symptoms used in situations involving clinical management of confirmed Vitamin A Deficiency (VAD). It is commonly used to help with symptoms of impaired vision, night blindness, and ocular surface damage such as keratomalacia. Furthermore, it plays a role in managing symptomatic clusters related to compromised systemic defenses and protective barriers.

The benefit contributes to easing the symptom load and supports general well-being during symptomatic phases. This preparation is commonly used for patient groups who experience difficulty absorbing fat-soluble vitamins, such as those with chronic malabsorption disorders.

“A-Viton may be part of symptomatic management to provide support during challenging phases of certain infectious diseases, such as measles, especially for vulnerable children.”


Quick Fact: Relief for Night Blindness

This may assist with managing difficulty seeing in low-light environments (night blindness), which assists with maintaining functional stability and general well-being.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility for A-Viton (Retinol/Vitamin A) — Official Regulatory Information

The eligibility profile for A-Viton is strictly defined by regulatory authorities, focusing on the potential for accumulation and toxicity, particularly in sensitive populations.

Classification Eligible Populations and Restrictions
Use is Established Individuals with confirmed Vitamin A Deficiency (VAD). Use is generally established across the pediatric, adult, and older adult populations for VAD treatment [Source: WHO, MedlinePlus].
Absolute Contraindication The medicine is strictly contraindicated for use in patients with pre-existing Hypervitaminosis A (Vitamin A toxicity) [Source: MedlinePlus].
Conditional/Restricted Use Pregnancy: Supplemental use of preformed Vitamin A is prohibited if the total daily intake exceeds the established Tolerable Upper Intake Level (UL) (typically 3,000 mcg RAE/day) due to severe teratogenic risk [Source: NIH ODS].
Comorbidity Restriction Use is strongly discouraged or requires close monitoring in patients with Severe Liver Disease (hepatic impairment), as the liver is the primary storage site, which increases the risk of toxicity [Source: Mayo Clinic].
Age Group Status Pediatric Use is established for VAD, but children are more sensitive to the toxic effects of excessive intake [Source: MedlinePlus]. Lactation (Breastfeeding) use is permitted to meet increased maternal and infant nutritional requirements [Source: NIH ODS].

What should I know about interactions with other medicines?

The regulatory interaction profile for A-Viton (Retinol/Vitamin A) is structured around two key constraints: minimizing the risk of systemic toxicity and preventing altered absorption.

The official documents state that co-administration with other oral retinoids (such as Isotretinoin) is restricted. This is due to a pharmacodynamic interaction where the combined intake causes an additive systemic exposure, significantly raising the formal risk of Hypervitaminosis A (Vitamin A toxicity). Similarly, high-dose Beta-Carotene supplements are cautioned against for the same reason.

A different pharmacodynamic interaction leads to restrictions with Tetracycline antibiotics, as the combination has been documented to increase the potential for Intracranial Hypertension. Furthermore, A-Viton may potentiate the effects of Warfarin, an anticoagulant, which increases the documented risk of bleeding.

Interactions based on pharmacokinetics include the effect of absorption-reducing agents. Substances like Orlistat and Mineral Oil formally decrease the gastrointestinal absorption of the fat-soluble A-Viton, leading to reduced exposure. To mitigate this effect, a mandatory two-hour separation is required between the administration of A-Viton and Orlistat.

A population-specific constraint is noted for patients with Hepatic or Biliary Dysfunction or a history of chronic alcohol abuse. These conditions are cited in interaction profiles because they can exacerbate the risk of Vitamin A toxicity due to altered metabolism and excretion of the substance.

Mechanism of Action

A-Viton exerts its primary action as a high-affinity agonist for the ubiquitous intracellular Vitamin D Receptor (VDR). Upon ligand binding, the VDR forms a heterodimer complex with the Retinoid X Receptor (RXR). This complex translocates to the cell nucleus where it binds to specific Vitamin D Response Elements (VDREs) on the DNA, altering the transcription rate of numerous target genes.

This genomic signaling cascade primarily affects pathways governing calcium and phosphate disposition. VDR activation upregulates proteins responsible for enhanced mineral absorption in the intestine and modulates the activity of bone cells (osteoblasts/osteoclasts) and renal handling of minerals. The resulting physiological consequence is the regulation of the systemic partitioning of calcium and phosphate, influencing the deposition and turnover of the skeletal structure.

A secondary mechanistic domain involves the VDR in immune cells and proliferating cell lines. By modulating genes controlling cytokine production and cellular differentiation, A-Viton influences inflammatory mediator synthesis and cell growth patterns.

Dosage and Administration Information

How to Use A-Viton

A-Viton (Retinol/Vitamin A) is administered according to regimens detailed in prescribing information, based on the severity of deficiency and the patient population. The medicine is available for administration via multiple routes, including oral, intramuscular (IM) injection, and intravenous (IV) infusion, with the choice of route dependent on clinical necessity, such as cases of severe malabsorption.

Dosing Regimens and Frequency

Standardized schedules specify both short-term high-dose therapy and long-term maintenance. For severe adult deficiency treated via IM injection, an initial dose of 100,000 IU once daily for three days is prescribed, followed by 50,000 IU once daily for an additional two weeks. Prophylaxis and oral maintenance typically utilize a lower, once-daily dose (e.g., 10,000 to 20,000 IU). High-dose oral regimens for acute ocular deficiency often follow a cyclic pattern, where 200,000 IU is given on Day 1, Day 2, and Day 8.

Administration Conditions

Due to the fat-soluble nature of A-Viton, oral forms are directed to be taken with or immediately after a meal to optimize systemic absorption. The injectable solution used in parenteral nutrition must be diluted into a large volume of the infusion solution prior to administration. Furthermore, specific maximum dose limits are established for vulnerable groups, such as children and pregnant patients. If a dose is missed and it is nearly time for the next scheduled administration, the instruction is to skip the missed dose rather than taking a double quantity.


Note: These administration guidelines define the protocol for using A-Viton.

Recent Clinical Evidence

Research Evidence / Overview of Studies for A-Viton


Evidence for Confirmed Vitamin A Deficiency (VAD)

Research for A-Viton (Retinol) has focused heavily on studies exploring A-Viton's role in the context of confirmed Vitamin A Deficiency (VAD). The core evidence base includes Randomized Controlled Trials (RCTs) and large systematic reviews, which were applied in studies examining how to restore the body’s essential nutrient supply. Researchers monitored outcomes related to functional imbalance and overall nutritional status in patients known to be deficient.

Studies reported measurements of circulating Retinol levels (a key biomarker) changing following A-Viton administration in individuals whose levels were low. This research helps contextualize how global health authorities, such as the WHO, incorporate A-Viton into guidelines for nutritional support when deficiency is present. What is still uncertain is related to the long-term management of VAD; research so far indicates that long-term outcomes are not fully established by existing clinical trials.


Evidence for Ocular Damage and Vision Issues

A-Viton was studied in research exploring its use for specific eye and vision issues that are direct consequences of VAD, such as night blindness and certain types of ocular surface damage (xerophthalmia). These studies primarily included RCTs that monitored outcomes related to functional measures, such as a patient's ability to see in low-light environments.

Studies reported changes in visual function following the administration of A-Viton to patients with deficiency-related night blindness. Trials reported documentation of changes in ocular surface damage symptoms specific to VAD following the administration of A-Viton. Evidence remains limited for the use of A-Viton in addressing eye or vision problems that are not caused by a confirmed Vitamin A deficiency.


Evidence for Support During Acute Infectious Diseases

A-Viton was evaluated in research exploring its use as a supportive measure during certain acute infectious diseases, most notably measles, particularly among vulnerable children. Studies reported observed patterns regarding complication rates and mortality measurements following A-Viton administration in the specific populations studied. This research has informed public health guidelines, especially in high-risk settings where children often have both acute infection and underlying VAD.


Long-Term Studies and Follow-Up

The majority of RCTs for A-Viton focus on the acute management of deficiency. Follow-up durations in interventional clinical trials were often limited to the immediate treatment or recovery period. Consequently, long-term effects on chronic health conditions or the durability of outcomes related to prolonged supplementation are not fully established. Research provides insight into short-term changes, but the data are still emerging regarding effects that would occur across the lifespan.

Key Studies & References Vitamin A and Carotenoids: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about A-Viton (FAQ)


Q: Can I take A-Viton every day for a long time?

Official product information emphasizes that long-term use of A-Viton at doses above the established daily limit ( 10,000 IU) is associated with an increased risk of chronic toxicity. This condition, known as hypervitaminosis A, is associated with the potential for developing symptoms and liver damage. Regulatory documents define the specific requirements for following prescribed dosing schedules.


Q: Are the side effects of A-Viton generally mild or serious?

Regulatory documents describe a range of potential side effects associated with A-Viton, including non-specific symptoms such as dry skin and hair loss. The documents also describe serious potential risks like liver damage and the risk of birth defects if excessive doses are taken during pregnancy, detailing the full spectrum of documented adverse effects.


Q: Is A-Viton an appropriate medicine for children?

Infants and young children are cited in official labeling as a group particularly susceptible to toxicity from A-Viton, even at lower doses than adults. Regulatory authorities have established specific maximum daily dose limits for different pediatric age groups to mitigate this heightened risk.


Q: Why do official documents describe A-Viton as a 'supportive' treatment?

Official research defines the use of A-Viton as a supportive measure in certain clinical contexts, such as during acute infectious diseases or for correcting a deficiency. This means its role is to help restore an essential nutrient supply rather than functioning as a primary, disease-modifying treatment.


Q: What are the most common non-serious side effects reported for A-Viton?

While frequency data is not always provided, regulatory labeling lists non-specific symptoms of chronic toxicity associated with excessive intake. These commonly reported effects include dry skin, cracked lips, hair loss, and fatigue.


Q: What does the research say about A-Viton's use in healthy individuals?

Regulatory nutritional guidelines emphasize that most healthy individuals who maintain a varied diet naturally obtain sufficient Vitamin A. Therefore, supplemental A-Viton is generally indicated for deficiency states rather than for use in healthy individuals for non-deficiency purposes.


Q: Do doctors often recommend A-Viton alongside other therapies?

Research evidence confirms A-Viton is utilized as a supportive measure in treating specific conditions, such as during certain acute infections. This supportive role indicates its use alongside primary treatments, which requires strict adherence to documented drug interaction guidelines.


Q: What information is publicly available about the safety profile of A-Viton?

Detailed information regarding the safety profile, side effects, and risk warnings for A-Viton is publicly available. Regulatory agencies like the FDA (DailyMed) and the NIH publish these official drug labels and public health resources for patient access.


Q: Is A-Viton a type of vitamin or a prescription drug?

A-Viton (Retinol/Vitamin A) is fundamentally an essential nutrient. Its regulatory status depends on the formulation: low-dose versions are available over-the-counter, but high-dose products intended for treating a confirmed deficiency are typically regulated as prescription medication.


Q: What is the main difference between A-Viton and similar over-the-counter supplements?

The primary distinction involves the dose and the regulatory status. Products like A-Viton that contain high-dose amounts are often prescription-only and intended to correct a confirmed deficiency, whereas most over-the-counter supplements provide lower, general dietary intake levels.


Q: Can older people safely use A-Viton?

Regulatory materials do not specifically list the elderly population as a group requiring distinct dosage adjustments or specific warnings, unlike other vulnerable groups such as children and pregnant women. General caution regarding toxicity risks, however, applies to all adults.


Q: Are there any specific foods I should avoid while using A-Viton?

Official drug interaction information cautions against excessive intake of other sources of preformed Vitamin A and high-dose Beta-Carotene supplements. This precaution is advised because combined intake can increase the risk of systemic Vitamin A toxicity (hypervitaminosis A).


Q: Does A-Viton have any effect on my weight?

Loss of appetite (anorexia) is listed in regulatory documents as a potential symptom associated with chronic A-Viton toxicity (hypervitaminosis A). The information does not indicate that A-Viton is intended to or typically causes weight change during appropriate use.


Q: Do I need a prescription from a doctor to get A-Viton?

The regulatory status varies depending on the product's concentration and intended use. While low-dose, general forms of the vitamin may be purchased over-the-counter, high-dose formulations designed for treating confirmed Vitamin A deficiency require a prescription.


Q: Is it okay to drive or operate machinery after taking A-Viton?

Regulatory warnings list potential side effects that include dizziness, severe headache, and blurred vision, particularly if toxicity occurs. These symptoms may temporarily impair the ability to operate machinery or drive safely.


Q: How is A-Viton different from the main treatment for my condition?

Research defines the role of A-Viton as a supportive measure used for specific purposes, such as correcting Vitamin A deficiency or providing support during certain acute infections. This distinguishes it from primary, curative, or disease-modifying therapies for a condition.


Q: Why is the mechanism of action of A-Viton described as 'complex'?

Official documents detail that the action involves multiple internal pathways, which contributes to its complexity. This mechanism includes genomic signaling (altering gene transcription) via the VDR/RXR complex and modulating pathways governing calcium, phosphate, and immune function.


Q: What should I do if I experience a mild side effect from A-Viton?

Regulatory guidelines contain statements that direct the user to discontinue the use of A-Viton and seek professional medical guidance if adverse reactions occur. This guidance is specifically provided for situations where signs of acute toxicity, such as nausea, vomiting, or dizziness, are present.


Q: Why do patient forums sometimes mention A-Viton causing 'jitters'?

Regulatory documents list certain symptoms of toxicity, such as irritability and changes in mental status, which are related to central nervous system effects. These specific effects might be informally described by users in patient forums using terms like 'jitters'.

How should A-Viton be stored and disposed of?

How to Store and Dispose of A-Viton?

The official labeled instructions define the mandatory conditions for storing and discarding A-Viton (Retinol/Vitamin A) to maintain its quality and ensure public safety.

Requirement Type Official Regulatory Statement
Storage Temperature Store at controlled room temperature, typically between 15 C and 30 C.
Environmental Protection Must be protected from light and excessive moisture. Do not freeze.
Container Mandate Keep the product in its original container and ensure the container is tightly closed.
Child Safety The medicine must be kept out of the sight and reach of children.
Disposal Guidelines Dispose of unused product according to local regulations. Utilize drug take-back programs if available. If a program is not available, mix the product with an unappealing substance like dirt or coffee grounds, seal it in a bag, and place it in the household trash (FDA guidance).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of A-Viton found in:

A-Z Index: